Showing 32,741 - 32,760 results of 103,943 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 1.63s Refine Results
  1. 32741

    Image_1_Vitamin A Deficiency in the Early-Life Periods Alters a Diversity of the Colonic Mucosal Microbiota in Rats.TIF by Baolin Chen (8317047)

    Published 2020
    “…The results showed that the concentrations of serum retinol were > ~1.05 μmol/L in maternal VA normal (VAN)rats and < 0.7 μmol/L in maternal VAD rats, while the serum retinol levels were higher than 0.7 μmol/L in the pups of the VAN group and below 0.5 μmol/L in the pups of the VAD group. Compared to the offspring persistent with VAN from embryonic stage (group A), all the remaining groups exhibited an increased ratio of Firmicutes/Bacteroidetes abundance. …”
  2. 32742

    Effects of Met concentrations 250μM-1mM on MYH1/2, Myf5, p21 and PGC-1α expression in myotubes. by Eleonora Maniscalco (14599854)

    Published 2023
    “…Met reduces MYH1/2 protein expression starting from 400μM, with a more evident decrease at 800μM and 1mM. The expression levels of Myf5 decreases after 400μM Met treatment and increases at higher concentrations especially at 800μM. …”
  3. 32743
  4. 32744
  5. 32745
  6. 32746

    <i>col27a1a</i> is required for notochord development. by Helena E. Christiansen (368143)

    Published 2013
    “…Dorsal (D) and lateral (F) views of <i>col27a1a</i> morphants at ∼5.6 SSL (14 dpf) show formation of notochord curves at the distal end of the tail. …”
  7. 32747

    Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  8. 32748

    Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  9. 32749

    Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  10. 32750

    Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  11. 32751

    Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  12. 32752

    Experimental and DFT Studies of Cationic Imido Titanium Alkyls:  Agostic Interactions and C−H Bond and Solvent Activation Reactions of Isolobal Analogues of Group 4 Metallocenium C... by Paul D. Bolton (2404816)

    Published 2006
    “…Reaction of <b>6</b><sup>+</sup> or <b>7</b><sup>+</sup> with Ph<sub>3</sub>PO afforded the adducts [Ti(N<sup>t</sup>Bu)(Me<sub>3</sub>[9]aneN<sub>3</sub>)R(Ph<sub>3</sub>PO)]<sup>+</sup>, whereas with pyridine a C−H bond activation reaction occurred to give [Ti(N<sup>t</sup>Bu)(Me<sub>3</sub>[9]aneN<sub>3</sub>)(NC<sub>5</sub>H<sub>4</sub>)]<sup>+</sup> (<b>17</b><sup>+</sup>) and the corresponding alkane RH. …”
  13. 32753
  14. 32754

    Minimal dataset for all analyses. by David J. Braun (7107692)

    Published 2023
    “…Beginning at 7.5 months of age, animals underwent behavioral assessment on the open field, followed by a later radial arm water maze test and collection of cortical and hippocampal tissues at 11 months. …”
  15. 32755
  16. 32756

    Image_5_Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Dat... by Xuejiao Yin (5132441)

    Published 2019
    “…The incidence-based mortality trend of extranodal DLBCL had a similar pattern, with a decrease happening around 1993. …”
  17. 32757
  18. 32758

    Table_1_Visual Cues Predictive of Behaviorally Neutral Outcomes Evoke Persistent but Not Interval Timing Activity in V1, Whereas Aversive Conditioning Suppresses This Activity.pdf by Kevin J. Monk (10258349)

    Published 2021
    “…We find that these conditioning strategies exhibit persistent activity that takes one of three forms, a sustained increase of activity; a sustained decrease of activity; or a delayed, transient peak of activity, as previously observed following conditioning with delayed reward. …”
  19. 32759

    Table_2_Visual Cues Predictive of Behaviorally Neutral Outcomes Evoke Persistent but Not Interval Timing Activity in V1, Whereas Aversive Conditioning Suppresses This Activity.pdf by Kevin J. Monk (10258349)

    Published 2021
    “…We find that these conditioning strategies exhibit persistent activity that takes one of three forms, a sustained increase of activity; a sustained decrease of activity; or a delayed, transient peak of activity, as previously observed following conditioning with delayed reward. …”
  20. 32760

    Table_3_Visual Cues Predictive of Behaviorally Neutral Outcomes Evoke Persistent but Not Interval Timing Activity in V1, Whereas Aversive Conditioning Suppresses This Activity.pdf by Kevin J. Monk (10258349)

    Published 2021
    “…We find that these conditioning strategies exhibit persistent activity that takes one of three forms, a sustained increase of activity; a sustained decrease of activity; or a delayed, transient peak of activity, as previously observed following conditioning with delayed reward. …”